This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
post featured image

FDA Warning Letter focuses on GMP failures at 503B compounding outsourcing facility
By Bethany Hills Hilary Hoffman
After a brief hiatus from the string of Warning Letters sent to 503B outsourcing facilities in mid- to late 2021, on June 7, 2022, FDA...